Showing results (41-50 of 341) with videos related to
Sort By:
Pageof 35
Clinical Endocrinology|April 24, 2018
Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associationsMarcus Quinkler, Bertil Ekman, Pinggao Zhang, et al.Phytochemistry|March 23, 2001
Lactone diterpenes from the aquatic plant Potamogeton natansT Cangiano, M DellaGreca, A Fiorentino, et al.Advances in Biological Regulation|February 6, 2026
Adrenergic receptor activation shapes circadian clock gene oscillations in HL-1 cardiomyocyte cell lineElena Crecca, Martina Pinna, Maria Rita Assenza, et al.Phytochemistry|September 12, 2001
Antialgal furano-diterpenes from Potamogeton natans LM DellaGreca, A Fiorentino, M Isidori, et al.The Journal of Sexual Medicine|March 6, 2016
Endocrinologic Control of Men's Sexual Desire and Arousal/ErectionGiovanni Corona, Andrea M Isidori, Antonio Aversa, et al.European Journal of Endocrinology|July 15, 2011
Onset of effects of testosterone treatment and time span until maximum effects are achievedFarid Saad, Antonio Aversa, Andrea M Isidori, et al.International Journal of Andrology|March 1, 2002
Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuracy and specificityAntonio Aversa, Andrea M Isidori, Massimiliano Caprio, et al.The Journal of Sexual Medicine|October 12, 2013
Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctionsEmmanuele A Jannini, Andrea M Isidori, Antonio Aversa, et al.Andrology|August 2, 2020
Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapyFranz Sesti, Riccardo Pofi, Marianna Minnetti, et al.European Journal of Endocrinology|October 4, 2014
Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysisDaniele Santi, Elisa Giannetta, Andrea M Isidori, et al.Pageof 35